Related references
Note: Only part of the references are listed.Short communication for targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches- part 2
Shailima Rampogu et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs
Marina K. Kukhanova et al.
MOLECULES (2020)
RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X
Sundy N. Y. Yang et al.
CELLS (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications
Beatrice E. Bachmeier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3
Rong Fu et al.
CELL DEATH & DISEASE (2019)
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X
Annalaura Brai et al.
MOLECULES (2019)
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
Saritha Tantravedi et al.
TRANSLATIONAL ONCOLOGY (2019)
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
M. R. Heerma van Voss et al.
ONCOGENE (2018)
A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression
Yu He et al.
ONCOLOGY REPORTS (2018)
Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
Marise R. Heerma van Voss et al.
TRANSLATIONAL ONCOLOGY (2018)
Recent Advances in the Treatment of Breast Cancer
Christy W. S. Tong et al.
FRONTIERS IN ONCOLOGY (2018)
Anticancer effect of curcumin on breast cancer and stem cells
Hui-Tien Liu et al.
FOOD SCIENCE AND HUMAN WELLNESS (2018)
The prognostic effect of DDX3 upregulation in distant breast cancer metastases
Marise R. Heerma van Voss et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Risk Factors and Preventions of Breast Cancer
Yi-Sheng Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
Myong Cheol Lim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
Marise R. Heerma van Voss et al.
ONCOTARGETS AND THERAPY (2017)
Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell
Xinzheng Wang et al.
ONCOLOGY LETTERS (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma
B. A. Wilky et al.
ONCOGENE (2016)
RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
Min Xie et al.
CANCER RESEARCH (2016)
DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis
Tsung-Ying He et al.
SCIENTIFIC REPORTS (2016)
In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3
Mahendran Botlagunta et al.
BIOINFORMATION (2016)
Therapeutic Applications of Curcumin Nanoformulations
Murali M. Yallapu et al.
AAPS JOURNAL (2015)
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
Guus M. Bol et al.
EMBO MOLECULAR MEDICINE (2015)
DDX3, a potential target for cancer treatment
Guus Martinus Bol et al.
MOLECULAR CANCER (2015)
NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3
Min Xie et al.
ONCOTARGET (2015)
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
Marise R. Heerma van Voss et al.
ONCOTARGET (2015)
Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer
Sabindra K. Samal et al.
SCIENTIFIC REPORTS (2015)
DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway
H-H Chen et al.
ONCOGENE (2015)
Update on prevention and screening of cervical cancer
Shaniqua L. McGraw et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication
Anthony Fullam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
Guus M. Bol et al.
PLOS ONE (2013)
The role of the DEAD-box RNA helicase DDX3 in mRNA metabolism
Ricardo Soto-Rifo et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors
Marco Radi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Protein-Ligand-Based Pharmacophores: Generation and Utility Assessment in Computational Ligand Profiling
Jamel Meslamani et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
The role of DDX3 in regulating Snail
Mianen Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy
Murielle Mimeault et al.
CHINESE MEDICINE (2011)
DDX3 Regulates Cell Growth through Translational Control of Cyclin E1
Ming-Chih Lai et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Oncogenic role of DDX3 in breast cancer biogenesis
M. Botlagunta et al.
ONCOGENE (2008)
Aromatase inhibitors: Are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
William R. Miller et al.
ONCOLOGIST (2008)
Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP
Martin Hogbom et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
RNA, helicases: Regulators of differentiation
M Abdelhaleem
CLINICAL BIOCHEMISTRY (2005)
Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function
VSRK Yedavalli et al.
CELL (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Exemestane, a new steroidal aromatase inhibitor of clinical relevance
P Lombardi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
The Binding Database: data management and interface design
X Chen et al.
BIOINFORMATICS (2002)
Share Paper
